FDA Warning Letter — QuVa Pharma, Inc.
The FDA took a Warning Letter action against QuVa Pharma, Inc. on January 26, 2024 (Bloomsbury, NJ). The action was issued by CDER and concerns drugs products. This facility has 4 recent FDA inspections on record.
Action Details
- Facility
- QuVa Pharma, Inc.
- Date
- January 26, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Center
- CDER
- Location
- Bloomsbury, NJ (United States)